TREM2 as potential research target for cancer therapeutics and related research tools

by | Jan 3, 2025 | Cancer, Immunology, in vivo Studies

ARTICLE FROM BIO X CELL

What Drives Myeloid Cell Responses to Disease

Bio X Cell has recently published an article discussing TREM2, a potential target for cancer therapeutics, and related research tools for studying TREM2, titled ‘What drives myeloid cell responses to disease’.

Distinguishing TREM2 from other TREM family members is crucial for understanding its specific functions and mechanisms. Bio X Cell offers a range of high-purity monoclonal antibodies, such as InVivoMAb anti-mouse TREM2 antibody, to support TREM2 and neuroscience-related research.

Click to read more. Let’s explore the comprehensive in-vivo antibodies library of Bio X Cell today!

Reference: Bio X Cell (2025)

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

ABOUT BIO X CELL

Antibodies For In Vivo Research

Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.

 

    • Exceptional Purity
    • Pathogen Free
    • Ultra-low Endotoxin Level
    • Advanced Binding Validation
    • Low Protein Aggregation
    • Marching Isotype Control Antibodies

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

Learn more on our comprehensive in-vivo research reagents today.

Contact us
Share This